相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacokinetics and Tolerance of the Phage Endolysin-Based Candidate Drug SAL200 after a Single Intravenous Administration among Healthy Volunteers
Soo Youn Jun et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Galleria mellonella infection models for the study of bacterial diseases and for antimicrobial drug testing
Catherine Jia-Yun Tsai et al.
VIRULENCE (2016)
Strain Specific Phage Treatment for Staphylococcus aureus Infection Is Influenced by Host Immunity and Site of Infection
Nathan B. Pincus et al.
PLOS ONE (2015)
Methicillin-Resistant Staphylococcus aureus Therapy: Past, Present, and Future
Keith A. Rodvold et al.
CLINICAL INFECTIOUS DISEASES (2014)
Combination Therapy With Lysin CF-301 and Antibiotic Is Superior to Antibiotic Alone for Treating Methicillin-Resistant Staphylococcus aureus-Induced Murine Bacteremia
Raymond Schuch et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
MICROBIOLOGY Phage therapy gets revitalized
Sara Reardon
NATURE (2014)
Characteristics of invasive Staphylococcus aureus infections in three regions of Korea, 2009-2011: a multi-center cohort study
Kyoung-Ho Song et al.
BMC INFECTIOUS DISEASES (2013)
Antibacterial properties of a pre-formulated recombinant phage endolysin, SAL-1
Soo Youn Jun et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Lysins: the arrival of pathogen-directed anti-infectives
Mina Pastagia et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2013)
Co-Therapy Using Lytic Bacteriophage and Linezolid: Effective Treatment in Eliminating Methicillin Resistant Staphylococcus aureus (MRSA) from Diabetic Foot Infections
Sanjay Chhibber et al.
PLOS ONE (2013)
MRSA: the first half century
Robert C. Moellering
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Comparison of the Antibacterial Properties of Phage Endolysins SAL-1 and LysK
Soo Youn Jun et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children
Catherine Liu et al.
CLINICAL INFECTIOUS DISEASES (2011)
Antibiotic Choice May Not Explain Poorer Outcomes in Patients With Staphylococcus aureus Bacteremia and High Vancomycin Minimum Inhibitory Concentrations
Natasha E. Holmes et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Synergism between a Novel Chimeric Lysin and Oxacillin Protects against Infection by Methicillin-Resistant Staphylococcus aureus
Anu Daniel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Bacteriophage lysins as effective antibacterials
Vincent A. Fischetti
CURRENT OPINION IN MICROBIOLOGY (2008)
Efficient elimination of multidrug-resistant Staphylococcus aureus by cloned lysin derived from bacteriophage φMR11
Mohammad Rashel et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Therapeutic effects of bacteriophage Cpl-1 lysin against Streptococcus pneumoniae endocarditis in rats
JM Entenza et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Bacteriophage endolysins - current state of research and applications
MJ Loessner
CURRENT OPINION IN MICROBIOLOGY (2005)
Removal of group B streptococci colonizing the vagina and oropharynx of mice with a bacteriophage, lytic enzyme
Q Cheng et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Synergistic lethal effect of a combination of phage lytic enzymes with different activities on penicillin-sensitive and -resistant Streptococcus pneumoniae strains
JM Loeffler et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: A meta-analysis
SE Cosgrove et al.
CLINICAL INFECTIOUS DISEASES (2003)
Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme
D Nelson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
分享论文
